Viatris Inc
VTRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001792044
No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.
Superinvestors holding VTRS, Q2 2026
1 superinvestor reports holding Viatris Inc on Form 13F, worth $44.0M in total. Weight is Viatris Inc's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Greenlight CapitalDavid Einhorn | 1.1% | 2,773,470 | $44.0M | Added+52.6% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of VTRS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+52.6%)
Q1 2026
1 superinvestor holding at quarter end
Q3 2025
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q2 2025
1 superinvestor holding at quarter end
- New
- Soros Fund Management
- Sold out
- Greenlight Capital
Q1 2025
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+3.7%)
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- Greenlight Capital (−20.4%)
- Sold out
- Soros Fund Management
Q3 2024
2 superinvestors holding at quarter end
- New
- Soros Fund Management
- Reduced
- Greenlight Capital (−1.7%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+63.8%)
Q1 2024
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+34.6%)
Q4 2023
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end